Lymphoepithelioma-like hepatocellular carcinoma: An uncommon variant of hepatocellular carcinoma with favorable outcome

American Journal of Surgical Pathology

Volumn 39, Issue 3, 2015, Pages 304-312

  Chan, Anthony W H ^a   Tong, Joanna H M ^a,c,d   Pan, Yi ^a,d   Chan, Stephen L ^b,c   Wong, Grace L H ^a,c   Wong, Vincent W S ^a,c   Lai, Paul B S ^a   To, Ka Fai ^a,c,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Departments of Clinical Oncology State Key Laboratory in Oncology in South China Prince of Wales Hospital   (France)

^c Partner State Key Laboratory of Digestive Disease   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

BRAF; hepatocellular carcinoma; hypermethylation; lymphoepithelioma; lymphoid stroma; microsatellite instability; tumor infiltrating lymphocyte

Indexed keywords

TUMOR MARKER;

ADULT; AGED; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CHI SQUARE DISTRIBUTION; CLASSIFICATION; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; FEMALE; GENETICS; HONG KONG; HUMAN; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LYMPHOMA; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HONG KONG; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; LYMPHOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84923911535     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000376     Document Type: Article

References (24)

1. Chan AW, Tong JH, Sung MY, et al. Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome. Histopathology. 2014;65:674-683.
2. Shirabe K, Matsumata T, Maeda T, et al. A long-term surviving patient with hepatocellular carcinoma including lymphocytes infiltration-a clinicopathological study. Hepatogastroenterology. 1995;42:996-1001.
3. Wada Y, Nakashima O, Kutami R, et al. Clinicopathological study on hepatocellular carcinoma with lymphocytic infiltration. Hepatology. 1998;27:407-414.
4. Emile JF, Adam R, Sebagh M, et al. Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology. 2000;37:523-529.
5. Si MW, Thorson JA, Lauwers GY, et al. Hepatocellular lymphoepithelioma-like carcinoma associated with epstein barr virus: a hitherto unrecognized entity. Diagn Mol Pathol. 2004;13:183-189.
6. Chen CJ, Jeng LB, Huang SF. Lymphoepithelioma-like hepatocellular carcinoma. Chang Gung Med J. 2007;30:172-177.
7. Nemolato S, Fanni D, Naccarato AG, et al. Lymphoepitelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Gastroenterol. 2008;14:4694-4696.
8. Park HS, Jang KY, Kim YK, et al. Hepatocellular carcinoma with massive lymphoid infiltration: a regressing phenomenon? Pathol Res Pract. 2009;205:648-652.
9. Shinoda M, Kadota Y, Tsujikawa H, et al. Lymphoepithelioma-like hepatocellular carcinoma: a case report and a review of the literature. World J Surg Oncol. 2013;11:97.
10. Theise ND, Curado MP, Franceshi S, et al. Hepatocellular carcinoma. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer; 2010:205-216.
11. Hamiton SR, Bosman FT, Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer; 2010:131-182.
12. Ogino S, Nosho K, Irahara N, et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res. 2009;15:6412-6420.
13. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
14. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
15. Selaru FM, David S, Meltzer SJ, et al. Epigenetic events in gastrointestinal cancer. Am J Gastroenterol. 2009;104:1910-1912.
16. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348:203-213.
17. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960-1964.
18. Lo KW, Chung GT, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol. 2012;22:79-86.
19. Song HJ, Srivastava A, Lee J, et al. Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology. 2010;139:84-92, e82.
20. Liang Y, Wang L, Zhu Y, et al. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up. Cancer. 2012;118:4748-4758.
21. Petrova M, Kamburov V. Epstein-Barr virus: silent companion or causative agent of chronic liver disease? World J Gastroenterol. 2010;16:4130-4134.
22. Stoot JH, Coelen RJ, De Jong MC, et al. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509-522.
23. Bioulac-Sage P, Sempoux C, Possenti L, et al. Pathological diagnosis of hepatocellular cellular adenoma according to the clinical context. Int J Hepatol. 2013;2013:253-261.
24. Chan AW, Tong JH, Chan SL, et al. Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma. Histopathology. 2014;64:935-950.